Publications by authors named "O M de Almeida"
Background: Current estimates of dementia and Alzheimer's disease incidence and prevalence are required to understand the health needs of the elderly.
Objective: We used two Australia cohort studies, administrative datasets, and data linkage techniques to estimate dementia rates in Australia.
Methods: The study used Australian Longitudinal Study on Women's Health and the Health in Men Cohort Study.
Purpose: To longitudinally evaluate sockets localization, tunnel morphological changes and graft maturation after the . We hypothesized that due the necessary angle for the inside-out reaming procedure, the described technique could input changes in the tibial socket.
Methods: Fourteen knees treated with the same all-inside ACLR technique were randomly assigned for a magnetic resonance evaluation.
Article Synopsis
- - An 81-year-old man was found to have a well-defined cyst in his jaw during a routine x-ray, which was thought to be a residual cyst and was surgically removed for analysis.
- - The analysis revealed that the cyst was mostly lined with a type of tissue associated with tooth development, showing unique features like ghost cells, along with other cystic structures.
- - The final diagnosis was a calcifying odontogenic cyst containing areas similar to an odontogenic keratocyst, a rare combination, with no signs of recurrence after 9 years of monitoring.
Introduction: Aboriginal and Torres Strait Islander peoples are the First Peoples of Australia. Up to 45% of dementia in these populations is due to potentially modifiable risk factors. The Dementia Prevention and Risk Management Program for Aboriginal Australians (DAMPAA) is an Aboriginal Health Practitioner led programme that aims to reduce cognitive decline and functional impairment in older Aboriginal people.
View Article and Find Full Text PDFAims: This study aimed to investigate acamprosate and naltrexone dispensing patterns in Australia.
Methods: A 10% representative sample of medications subsidized by the Australian Pharmaceutical Benefits Scheme (PBS) was used to identify individuals who were dispensed naltrexone or acamprosate between January 2006 and December 2023. Data were used to examine concurrent dispensing, medication switching and treatment episode length, as well as changes in prevalence and incidence over time.